Novel Antibiotic Shows Promise for C diff Infection : vimars

A novel antibiotic therapy for Clostridioides difficile infection, currently dubbed CRS3123, has demonstrated narrower selectivity and reduced bacterial derangement in the gut compared with other antibiotics.

Related Keywords

Colorado , United States , Denver , Katherine Johnson , Byron Vaughn , Centers For Disease , University Of Minnesota , Peggy Lillis Foundation , Western Infectious Disease Consultants , Disease Control , Medscape Medical , Lillis Foundation , Advocacy Summit , Presented May , C Diff Infection , Clostridium Difficile Infection , Lostridium Difficile Associated Disease , C Diff Associated Disease , Antibiotics , Igecycline , Infection Control , Bacteria , Clinical Research , Clinical Trials , Linical Studies , Healthcare And Medical Technology , Ealth And Medical Tech , Ealth And Med Tech , Ealth And Medical Technology , Activism , Activist , Animal Research , , Social Issues , Toxicology ,